PAR 4.08% 25.5¢ paradigm biopharmaceuticals limited..

PAR. SP, page-816

  1. 9,806 Posts.
    lightbulb Created with Sketch. 1243
    Not for DMOAD it isn't

    So this strategy shouldn't become a distraction for P3 or deals in ALL KEY MARKETS
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.